首页 > 新闻资讯 > 最新新闻

最新新闻

ENHERTU® Granted Priority Review in the U.S. for Patients with Previously Treated HER2 Mutant Metast

Press Release_ENHERTU Granted Priority Review in the U.S. for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer


2022-04-19

了解更多

strategy
公司介绍

第一三共在中国已开展了三十年的业务,我们提供的医药产品覆盖各治疗领域.

更多...